The Swiss Are On The Offensive Against Cancer
Exelixis has just introduced a new drug aimed to fight advanced melanoma. On this video segment, Motley Fool analyst Kristine Harjes and Fool contributor Todd Campbell discuss the new players in a seemingly crowded biotech landscape.
This podcast was recorded on 11/11/2015.